Unmasking Leishmaniasis: A Deep Dive into the Moroccan Outbreak
"New research sheds light on the causative agent behind the Chichaoua province outbreak, offering hope for targeted treatments."
Cutaneous leishmaniasis (CL), a parasitic disease affecting the skin, is caused by various species of Leishmania. In Morocco, three species are responsible: Leishmania major, L. tropica, and L. infantum. For years, CL has been present in the Chichaoua province. Recent research has identified L. tropica as the primary culprit behind the region's outbreak.
Traditionally, L. major was more common south of the Atlas Mountains, while L. infantum appeared in the north. L. tropica has also been reported, but a recent surge in Chichaoua raised concerns, with initial cases reported in 2000. Given the implications for treatment and public health strategies, identifying the specific Leishmania species became crucial.
This article breaks down the research that used advanced molecular techniques (ITS1 PCR-RFLP assay) on samples collected in 2006 and 2009 to definitively identify L. tropica. It also looks at how this identification method works, what the findings mean for managing the disease, and what other factors might contribute to the changing patterns of leishmaniasis in Morocco.
Global Burden and Consequences
The World Health Organization's Global Health Observatory provides reported case data for cutaneous leishmaniasis across its 194 Member States. Cutaneous leishmaniasis is a zoonotic parasitic disease caused by Leishmania infection and transmitted through sandfly bites. Lesions often begin as painless bites and progress to ulcers; although many heal spontaneously, they can leave disfiguring scars, psychological distress, lifelong scarring, and stigma.
Diagnosis and Its Constraints
Diagnosis of leishmaniasis remains challenging, particularly when species must be detected and correctly identified in endemic areas with limited resources. Available approaches include cultivation and molecular testing, while TS1-PCR-RFLP has been used to identify L. tropica. One comparative study concluded that PCR was the most sensitive method for diagnosing cutaneous leishmaniasis and was valuable for distinguishing Leishmania species with confusing dermatropic signs.
From Ancient Evidence to Modern Identification
Historical reviews trace the origin of the Leishmania genus to the Mesozoic era and describe its subsequent geographical distribution. They also document ancient references to skin disease, including reports of the Nile pimple, and evidence of Leishmania-infected macrophages in a six-year-old Peruvian mummy dated to 800 BCE. Modern milestones included the recognition of Leishmania parasites as the causative agents of leishmaniasis.
The Science Behind the Identification: Unlocking the Culprit
The study focused on samples from patients with suspected cutaneous leishmaniasis. Researchers collected slides from active lesions, stained them with Giemsa, and looked for the presence of parasites (amastigotes) under a microscope. For confirmation, the parasites were cultured. This allowed researchers to collect enough material to analyze the Leishmania DNA.
- DNA Extraction: First, DNA was extracted from both microscopic slides and parasite cultures.
- PCR Amplification: The internal transcribed spacer 1 (ITS1) region of the ribosomal RNA gene was amplified using the polymerase chain reaction (PCR). This process creates multiple copies of the target DNA.
- RFLP Analysis: The amplified DNA was then subjected to restriction fragment length polymorphism (RFLP) analysis using the HaeIII enzyme. This enzyme cuts the DNA at specific sequences, resulting in unique fragment patterns depending on the Leishmania species.
- Fragment Analysis: The resulting DNA fragments were separated by gel electrophoresis, and the unique patterns were compared to reference strains (L. tropica, L. major, and L. infantum) for accurate identification.
Morocco's Species and Vector Landscape
Recent Moroccan field research examined gut bacteria in natural sand fly populations from endemic and non-endemic areas. Lalla Aaziza was studied as an active focus of cutaneous leishmaniasis caused by L. tropica, with occasional visceral leishmaniasis cases due to L. infantum, while Marrakech was considered non-endemic. Moroccan research also identifies L. major and L. tropica as endemic species causing zoonotic and anthroponotic cutaneous leishmaniasis, respectively, and reports 5,073 cases to the Ministry of Health in 2016.
Treatment Depends on Context
Cutaneous leishmaniasis is transmitted by infected sandflies, but its management varies according to species and clinical setting. The CDC states that treatment decisions should be individualized with expert consultation and that not every cutaneous case requires treatment. By contrast, all clinically manifest cases of visceral and mucosal leishmaniasis should generally be treated, while topical-treatment reviews have compared paromomycin regimens with meglumine antimoniate.
What This Discovery Means for Morocco and Beyond
The identification of L. tropica as the causative agent of cutaneous leishmaniasis in Chichaoua province marks a turning point in understanding and managing the disease in Morocco. This knowledge is essential for public health planning. Knowing the specific species allows for more targeted treatment strategies and preventative measures.
Species-Specific Evidence and Therapy
A study of cutaneous leishmaniasis in Chichaoua province found that parasites in all analyzed clinical samples and cultures were identified as L. tropica through their typical restriction profiles. A separate systematic review and meta-analysis assessed systemic treatments across 83 studies involving 4,603 patients. It reported that the efficacy of meglumine antimoniate, miltefosine, azoles, pentamidine, and liposomal amphotericin B varied by region and species, while miltefosine showed consistent evidence across multiple settings.
Toward Better Control
Cutaneous leishmaniasis remains classified by the World Health Organization as a neglected tropical disease. A 2026 review reports that infected female sandflies of the Phlebotomus and Lutzomyia genera transmit the disease. The same review cites a WHO estimate of 600,000 to 1 million new cases worldwide annually, underscoring the need for continued advances in prevention, diagnosis, and treatment.
Disease Beyond Borders
A reported case involved a migrant Bangladeshi worker in Saudi Arabia with an imported case of cutaneous leishmaniasis caused by L. tropica. The infection was initially suspected to be cutaneous tuberculosis before specimens were referred for laboratory testing. Clinical descriptions also divide cutaneous leishmaniasis into localized, diffuse, recurrent, and post-kala-azar dermal forms, illustrating the condition's varied presentation.
Several factors could be driving the emergence of L. tropica, including ecological changes, urbanization, and even human and animal migration. As the risk patterns for CL evolve, continuous monitoring and adaptive strategies are necessary.
Future research should focus on several key areas: determining if a single or multiple strains of L. tropica are responsible, pinpointing the transmission factors involved, and actively engaging local communities in surveillance and control efforts. These steps are vital to creating effective strategies to combat leishmaniasis and safeguard public health.